Role of The Mitok ATP Channel in Digitalis Signaling in the Heart

$464,056P01FY2009HLNIH

University Of Toledo Health Sci Campus, Toledo OH

Investigators

Linked publications & trials

Paper 31360524 Paper 30041547 Paper 29419572 Paper 29233620 Paper 29064846 Paper 26961431 Paper 26587223 Paper 26388265 Paper 26374765 Paper 26295826 Paper 26219866 Paper 25575882 Paper 25085348 Paper 24894542 Paper 24667596 Paper 24266852 Paper 24258517 Paper 24186357 Paper 23800882 Paper 23288841 Paper 23203972 Paper 23086991 Paper 22966876 Paper 22811560 Paper 22579740 Paper 22451662 Paper 22240339 Paper 21905705 Paper 21784855 Paper 21555512 Paper 21362623 Paper 21189264 Paper 21048163 Paper 20500835 Paper 20451529 Paper 20335388 Paper 20302352 Paper 20144708 Paper 20010435 Paper 19884563 Paper 19506077 Paper 19363037 Paper 19353252 Paper 19329430 Paper 19118560 Paper 18794328 Paper 18697994 Paper 18621853 Paper 18349172 Paper 18283487 Paper 18094034 Paper 18006449 Paper 17993456 Paper 17951366 Paper 17936318 Paper 17728397 Paper 17721811 Paper 17592128 Paper 17535733 Paper 17349614 Paper 17335777 Paper 17296611 Paper 17272855 Paper 17157283 Paper 17098831 Paper 17045923 Paper 16960097 Paper 16798828 Paper 16720572 Paper 16698801 Paper 16624992 Paper 16525125 Paper 16473956 Paper 16267270 Paper 15975899 Paper 15970564 Paper 15602003 Paper 15256370 Paper 15138282 Paper 15123703 Paper 14993422 Paper 14963033 Paper 14749213 Paper 14656723 Paper 14507425 Paper 14507424 Paper 12763870 Paper 12763830 Paper 12763794 Paper 12658063 Paper 12619881 Paper 12606314 Paper 12578394 Paper 12063165 Paper 12055100 Paper 12027880 Paper 12022876 Paper 11988103 Paper 11907028 Paper 11880279

Abstract

Cardiac infarction followed by ischemic injury is a major cause of death worldwide. Digitalis, the oldest and best characterized heart failure drug, protects against ischemia-reperfusion injury, and it does so through activation of the mitochondrial ATP-sensitive K+ channel (mitoKATp). The central hypothesis of this project is that ouabain-activated signals are relayed to mitochondria, resulting in mitoKATp opening, increased production of reactive oxygen species (ROS) and activation of survival kinases that protect the heart. Our long-term goal is to uncover the mechanisms that regulate digitalis-induced cardioprotection through activation of the Na,K-ATPase / mitoKATp pathway. During this period, we will focus on the mechanism of signal transmission from the sarcolemmal Na,K-ATPase to mitochondria. Aim 1 will test the hypothesis that digitalis causes formation of functionally active caveolar microdomains (signalosomes) that interact with the mitochondrial outer membrane, leading to mitoKATp opening and inhibition of the mitochondrial permeability transition. Aim 2 will investigate signalosome recycling and the persistence of signalosome function. Aim 3 will investigate signalosome assembly and transport using electron microscopy and immunogold labeling. Aim 4 will investigate key aspects of digitalis protection and signaling in the rabbit heart model, whose cardiac function and digitalis pharmacology are closer to those in human heart. A variety of experimental approaches will be used. Signalosomes will be purified from perfused hearts and tested for functional activity on mitochondria isolated from untreated hearts. Results of these physiological studies will be supported by parallel studies of infarct size on perfused hearts. Purified signalosomes will also be subjected to biochemical and structural analyses to characterize their composition and origin.

View original record on NIH RePORTER →